The effect of intracerebroventricular indomethacin on osmotically stimulated vasopressin release

P. K. Hoffman, L. Share, J. T. Crofton, R. E. Shade

    Research output: Contribution to journalArticle

    19 Scopus citations

    Abstract

    Experiments were carried out to investigate the effect of intracerebroventricular administration of a prostaglandin synthesis inhibitor on the osmotic control of vasopressin (ADH) secretion. During ventriculocisternal perfusion with indomethacin (7.6 μg/min) or vehicle, dogs were infused intravenously with either 2.5 or 0.15 M NaCl. Hypertonic saline infusion elevated plasma osmolality approximately 60 mosm/kg H2O. In accordance, the plasma ADH concentration increased substantially in animals perfused ventriculocisternally with the vehicle (from 2.1 ± 0.7 to 7.3 ± 1.3 μU/ml); this response was markedly attenuated, however, in animals perfused with indomethacin (from 1.0 ± 0.2 to 2.2 ± 0.4 μU/ml). Isotonic saline infusion caused a decline in plasma ADH concentration which was similar in the indomethacin- and vehicle-perfused groups. Mean arterial blood pressure was unchanged during the experiments. In a companion study, ventriculocisternal perfusion with 152 ng PGE2/min was found to be as effective in stimulating ADH release in the presence of indomethacin as in its absence, indicating that the action of indomethacin in the first study was not nonspecific. The suppression of osmotically induced ADH release by intracerebroventricular indomethacin suggests that endogenous brain prostaglandins play a critical intermediary role in the osmotic control of ADH secretion.

    Original languageEnglish (US)
    Pages (from-to)132-139
    Number of pages8
    JournalNeuroendocrinology
    Volume34
    Issue number2
    DOIs
    Publication statusPublished - Jan 1 1982

      Fingerprint

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Endocrinology
    • Endocrine and Autonomic Systems
    • Cellular and Molecular Neuroscience

    Cite this